Renowned luminaries in Personalized Medicine
Groundbreaking companies with emerging technologies
More than 1000 peers from around the globe
50 sessions in 3 parallel tracks

CO-HOSTED WITH
STANFORD HEALTH CARE, UCSF, & ORACLE

The Patient Experience

How is today’s patient experience different from prior to the emergence of personalized medicine and the Affordable Care Act? A “real world”patient experience will be examined through multiple lenses including that of a patient who has survived cancer following precision medicine treatment. ASCO’s Chief Medical Officer, and a renowned clinical oncologist.From diagnosis and treatment toongoing disease management and paying for advanced care, the convergence of scientific advancement and a challenging medical economy has createda new paradigm. What working and what challenges remain?

FEATURED SPEAKERS

christine-bray.jpg

Christine Bray, Patient

In 2010, 30 year old Christine Bray was diagnosed with stage I ovarian cancer. Following surgery and chemotherapy, she experienced two recurrences within a year..With her early stage cancer proving to be very aggressive, her doctors feared she may not make it through the summer. But Christine wasn’t ready to give up. Read Full Bio

John E. Steiner, Chief Compliance & Privacy Officer & Associate General Counsel, CTCA

John E. Steiner, Jr. is the Chief Compliance and Privacy Officer and Associate General Counsel for Cancer Treatment Centers of America (CTCA). He is responsible for thedesign, implementation and administration of the enterprise compliance program. Read Full Bio

Richard L. Schilsky, M.D., FACP, FASCO, Chief Medical Officer, American Society of Clinical Oncology

Dr. Schilsky earned his M.D. at the University of Chicago Pritzker School of Medicine in 1975. Following a residency in Internal Medicine at the University of Texas Southwestern Medical Center and Parkland Memorial Hospital, he received training in Medical Oncology and Clinical Pharmacology at the National Cancer Institute (NCI) from 1977 to 1981. Read Full Bio

Moderator: Maurie Markman, M.D., Oncologist and President, Medicine & Science, CTCA

Dr. Maurie Markman is the President, Medicine & Science, Cancer Treatment Centers of America, and for more than 25 years has been engaged in clinical research for gynecologic malignancies, focusing on new drug development and exploring novel management strategies. Read Full Bio

For more go to: http://2016sv.pmwcintl.com/

 
Web Analytics